Heffernan Michael Thomas
CIK 0001448914
Director
Filings
18
Latest Apr 30, 2026
Issuers covered
7
Showing
18 of 18
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Heffernan Michael Thomas. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Heffernan Michael Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHVN | Biohaven Ltd. | 4 | Apr 30, 2026 |
| COLL | Collegium Pharmaceutical, Inc | 4 | Feb 12, 2025 |
| TRVI | Trevi Therapeutics, Inc. | 4 | Jun 13, 2025 |
| AVTX | Avalo Therapeutics, Inc. | 2 | Jun 18, 2025 |
| SYBX | Synlogic, Inc. | 2 | Jun 26, 2023 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | 1 | Apr 29, 2022 |
| ENGN | Engene Holdings Inc. | 1 | Jul 10, 2025 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|